Enzon Pharmaceuticals Inc. (ENZN)

[aquaspin]

I had thought for sure that we would see a pullback yesterday after the recent run ENZN has been having.

In addition to the $48 million cash, $100 million NOLs, and Icahn owning nearly half the OS, ENZN will get 0.75% of all sales of SESN’s drug for 10 years once approved. They will also get $3.5 million milestone payments for each country that approves it as well.